These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25049013)

  • 1. Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidney disease.
    Charytan DM; Padera R; Helfand AM; Zeisberg M; Xu X; Liu X; Himmelfarb J; Cinelli A; Kalluri R; Zeisberg EM
    Int J Cardiol; 2014 Sep; 176(1):99-109. PubMed ID: 25049013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Endothelial (dys)Function, Left Ventricular Structure and Function in Patients with Chronic Kidney Disease.
    Bartnicki P; Kowalczyk M; Franczyk-Skóra B; Baj Z; Rysz J
    Curr Vasc Pharmacol; 2016; 14(4):360-7. PubMed ID: 26759218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nur77 deficiency exacerbates cardiac fibrosis after myocardial infarction by promoting endothelial-to-mesenchymal transition.
    Chen J; Jia J; Ma L; Li B; Qin Q; Qian J; Ge J
    J Cell Physiol; 2021 Jan; 236(1):495-506. PubMed ID: 32542822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of circulating angiogenesis inhibitors and asymmetric dimethyl arginine with coronary plaque burden.
    Charytan DM; Cinelli A; Zeisberg EM
    Fibrogenesis Tissue Repair; 2015; 8():13. PubMed ID: 26213574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value and level of circulating endothelial progenitor cells, angiogenesis factors and mononuclear cell apoptosis in patients with chronic kidney disease.
    Chen YT; Cheng BC; Ko SF; Chen CH; Tsai TH; Leu S; Chang HW; Chung SY; Chua S; Yeh KH; Chen YL; Yip HK
    Clin Exp Nephrol; 2013 Feb; 17(1):83-91. PubMed ID: 22814956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis.
    Du JK; Yu Q; Liu YJ; Du SF; Huang LY; Xu DH; Ni X; Zhu XY
    Theranostics; 2021; 11(9):4207-4231. PubMed ID: 33754057
    [No Abstract]   [Full Text] [Related]  

  • 7. The mechanism of TGF-β/miR-155/c-Ski regulates endothelial-mesenchymal transition in human coronary artery endothelial cells.
    Wang J; He W; Xu X; Guo L; Zhang Y; Han S; Shen D
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28607031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bradykinin attenuates endothelial-mesenchymal transition following cardiac ischemia-reperfusion injury.
    Song J; Du J; Tan X; Chen H; Cong B
    Eur J Pharmacol; 2024 May; 971():176556. PubMed ID: 38574840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating angiopoietin-2 levels increase with progress of chronic kidney disease.
    David S; Kümpers P; Lukasz A; Fliser D; Martens-Lobenhoffer J; Bode-Böger SM; Kliem V; Haller H; Kielstein JT
    Nephrol Dial Transplant; 2010 Aug; 25(8):2571-6. PubMed ID: 20179005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of prostaglandin E2 receptor 4 by lnc000908 to promote the endothelial-mesenchymal transition participation in cardiac remodelling.
    Chen X; Ge W; Hu J; Dong T; Yao H; Chen L; Geng B; Zhou H
    J Cell Mol Med; 2019 Sep; 23(9):6355-6367. PubMed ID: 31297954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological inhibition of β-catenin prevents EndMT in vitro and vascular remodeling in vivo resulting from endothelial Akt1 suppression.
    Sabbineni H; Verma A; Artham S; Anderson D; Amaka O; Liu F; Narayanan SP; Somanath PR
    Biochem Pharmacol; 2019 Jun; 164():205-215. PubMed ID: 30991049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetric dimethylarginine and angiopoietin-like protein-2 are independent predictors of cardiovascular risk in pre-dialysis non-diabetic chronic kidney disease patients.
    Ashokachakkaravarthy K; Rajappa M; Parameswaran S; Satheesh S; Priyadarshini G; Mohan Raj PS; Revathy G; Priyadarssini M
    Int Urol Nephrol; 2020 Jul; 52(7):1321-1328. PubMed ID: 32409974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating levels of dimethylarginines, chronic kidney disease and long-term clinical outcome in non-ST-elevation myocardial infarction.
    Cavalca V; Veglia F; Squellerio I; De Metrio M; Rubino M; Porro B; Moltrasio M; Tremoli E; Marenzi G
    PLoS One; 2012; 7(11):e48499. PubMed ID: 23185262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease.
    He J; Xu Y; Koya D; Kanasaki K
    Clin Exp Nephrol; 2013 Aug; 17(4):488-97. PubMed ID: 23430391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased circulating trimethylamine N-oxide contributes to endothelial dysfunction in a rat model of chronic kidney disease.
    Li T; Gua C; Wu B; Chen Y
    Biochem Biophys Res Commun; 2018 Jan; 495(2):2071-2077. PubMed ID: 29247650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF23 impairs peripheral microvascular function in renal failure.
    Verkaik M; Juni RP; van Loon EPM; van Poelgeest EM; Kwekkeboom RFJ; Gam Z; Richards WG; Ter Wee PM; Hoenderop JG; Eringa EC; Vervloet MG;
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1414-H1424. PubMed ID: 30028196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease.
    Rastogi A
    Ther Adv Cardiovasc Dis; 2013 Dec; 7(6):322-42. PubMed ID: 24327730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype.
    Shroff R; Speer T; Colin S; Charakida M; Zewinger S; Staels B; Chinetti-Gbaguidi G; Hettrich I; Rohrer L; O'Neill F; McLoughlin E; Long D; Shanahan CM; Landmesser U; Fliser D; Deanfield JE
    J Am Soc Nephrol; 2014 Nov; 25(11):2658-68. PubMed ID: 24854267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced Microvascular Density in Omental Biopsies of Children with Chronic Kidney Disease.
    Burkhardt D; Bartosova M; Schaefer B; Grabe N; Lahrmann B; Nasser H; Freise C; Schneider A; Lingnau A; Degenhardt P; Ranchin B; Sallay P; Cerkauskiene R; Malina M; Ariceta G; Schmitt CP; Querfeld U
    PLoS One; 2016; 11(11):e0166050. PubMed ID: 27846250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empagliflozin restores chronic kidney disease-induced impairment of endothelial regulation of cardiomyocyte relaxation and contraction.
    Juni RP; Al-Shama R; Kuster DWD; van der Velden J; Hamer HM; Vervloet MG; Eringa EC; Koolwijk P; van Hinsbergh VWM
    Kidney Int; 2021 May; 99(5):1088-1101. PubMed ID: 33359500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.